Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis

Diseases of the Colon and Rectum

Volumn 54, Issue 11, 2011, Pages 1392-1397

  Lindström, Lina ^a   Lapidus, Annika ^b   Öst, Åke ^c   Bergquist, Annika ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ERSTA HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Colorectal cancer; Crohn's colitis; Inflammatory bowel disease; Primary sclerosing cholangitis

Indexed keywords

ADOLESCENT; ADULT; ANUS FISTULA; ARTICLE; CANCER RISK; CHILD; COHORT ANALYSIS; COLON BIOPSY; COLON CROHN DISEASE; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; DYSPLASIA; FEMALE; GRANULOMA; HUMAN; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MALE; PRIMARY SCLEROSING CHOLANGITIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOLANGITIS, SCLEROSING; COHORT STUDIES; COLITIS; COLORECTAL NEOPLASMS; CROHN DISEASE; DISEASE-FREE SURVIVAL; ENDOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; YOUNG ADULT;

EID: 80455130059     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e31822bbcc1     Document Type: Article

References (31)

1. Broome U, Olsson R, Loof L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996;38:610-615. (Pubitemid 26111384)
2. Broome U, Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis. 2006; 26:31-41. (Pubitemid 43320725)
3. Moayyeri A, Daryani NE, Bahrami H, Haghpanah B, Nayyer- Habibi A, Sadatsafavi M. Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis. J Gastroenterol Hepatol. 2005;20:366-370. (Pubitemid 40469335)
4. Lundqvist K, Broome U. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study. Dis Colon Rectum. 1997; 40:451-456. (Pubitemid 27172624)
5. Loftus EV Jr, Harewood GC, Loftus CG, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91-96. (Pubitemid 40007225)
6. Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:738-745.
7. Gillen CD, Walmsley RS, Prior P, et al. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut. 1994;35:1590-1592. (Pubitemid 24339258)
8. Gillen CD, Andrews HA, Prior P, et al. Crohn's disease and colorectal cancer. Gut. 1994;35:651-655. (Pubitemid 24163792)
9. Ekbom A, Helmick C, Zack M, et al. Increased risk of largebowel cancer in Crohn's disease with colonic involvement. Lancet. 1990;336:357-359. (Pubitemid 20264156)
10. Askling J, Dickman PW, Karlen P, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001;120:1356-1362. (Pubitemid 32322309)
11. Eaden JA, Mayberry JF. Colorectal cancer complicating ulcerative colitis: a review. Am J Gastroenterol. 2000;95:2710-2719.
12. Sokol H, Cosnes J, Chazouilleres O, et al. Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World J Gastroenterol. 2008;14: 3497-3503.
13. Lapidus A, Bernell O, Hellers G, et al. Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients. Gastroenterology. 1998;114:1151-1160. (Pubitemid 28243900)
14. Lapidus A, Bernell O, Hellers G, et al. Incidence of Crohn's disease in Stockholm County 1955-1989. Gut. 1997;41:480-486. (Pubitemid 27448779)
15. Wiesner RH, Ludwig J, LaRusso NF, et al. Diagnosis and treatment of primary sclerosing cholangitis. Semin Liver Dis. 1985;5: 241-253.
16. Chapman RW, Arborgh BA, Rhodes JM, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980;21:870-877. (Pubitemid 11198911)
17. Bjornsson E, Olsson R, Bergquist A, et al. The natural history of small-duct primary sclerosing cholangitis. Gastroenterology. 2008;134:975-980. (Pubitemid 351451987)
18. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6, 16-19. (Pubitemid 20015811)
19. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Human Pathol. 1983;14:931-968.
20. Soetikno RM, Lin OS, Heidenreich PA, et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc. 2002;56:48-54. (Pubitemid 41115048)
21. Lindberg BU, Broome U, Persson B. Proximal colorectal dysplasia or cancer in ulcerative colitis: the impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study. Dis Colon Rectum. 2001;44:77-85. (Pubitemid 32105878)
22. Claessen MM, Lutgens MW, van Buuren HR, et al. More rightsided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis. Inflamm Bowel Dis. 2009;15:1331-1336.
23. Tung BY, Emond MJ, Haggitt RC, et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med. 2001;134:89-95. (Pubitemid 32096335)
24. Pardi DS, Loftus EV Jr, Kremers WK, et al. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology. 2003;124: 889-893. (Pubitemid 36389790)
25. Eaden J, Abrams K, Ekbom A, et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther. 2000;14:145-153. (Pubitemid 30088290)
26. Orchard TR, Thiyagaraja S, Welsh KI, et al. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology. 2000;118:274-278. (Pubitemid 30067500)
27. Sandler RS, Loftus EV Jr. Epidemiology of inflammatory bowel disease. In: Sartor S, ed. Kirsner's Inflammatory Bowel Disease. Philadelphia, PA: Saunders; 2004:245-262.
28. Loftus EV Jr, Sandborn WJ, Tremaine WJ, et al. Primary sclerosing cholangitis is associated with nonsmoking: a case-control study. Gastroenterology. 1996;110:1496-1502. (Pubitemid 26134082)
29. Yao T, Matsui T, Hiwatashi N. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum. 2000; 43(10 suppl):S85-S93.
30. Munkholm P, Langholz E, Nielsen OH, et al. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol. 1992;27:609-614.
31. Goebell H, Dirks E, Förster S, et al. A prospective analysis of the incidence and prevalence of Crohn's disease in an urban population in Germany. Eur J Gastroenterol Hepatol. 1994;6:1039-1045. (Pubitemid 24322876)